This Follow-up Extension Study is Aimed to Monitor the Long-term IOP-lowering Performance/Efficacy and Safety of the MINT® Procedure in Open Angle Glaucoma Eyes.

NAActive, not recruitingINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

June 16, 2025

Primary Completion Date

June 30, 2025

Study Completion Date

July 21, 2025

Conditions
GlaucomaOcular HypertensionOpen-Angle Glaucoma
Interventions
DEVICE

MINT Minimally Invasive Nasal Trabeculostomy

The MINT® system is a powered surgical device for ab-interno nasal trabeculostomy. It creates \~100-micron trabeculostomy openings from the anterior chamber into Schlemm's canal by removing trabecular meshwork (TM) segments. The system includes a sterile stainless-steel Surgical Device with a micro trephine, driven by a motorized Activation Device that controls rotation and movement. The procedure facilitates aqueous outflow to lower IOP, with minimal collateral tissue damage.

Trial Locations (1)

Unknown

Ophthalmological Center After S.V Malayan, Yerevan

All Listed Sponsors
lead

Sanoculis Ltd

INDUSTRY